Turn Therapeutics Inc.·4

Apr 3, 8:09 AM ET

BEB Holdings, LLC 4

Research Summary

AI-generated summary

Updated

Turn Therapeutics (TTRX) CEO Bradley Burnam Gifts 300,000 Shares

What Happened

  • Bradley Evan Burnam, CEO of Turn Therapeutics (TTRX), reported a gift (transaction code G) disposing of 300,000 shares on 2026-04-02. The reported price is $0.00, so the disposition value is $0. This was a transfer by gift, not an open-market sale or purchase.

Key Details

  • Transaction date: 2026-04-02; Form 4 filed: 2026-04-03 (timely filing).
  • Transaction type/code: Gift (G); amount disposed: 300,000 shares; reported price: $0.00; reported value: $0.
  • Shares owned after transaction: Not specified in the provided filing.
  • Notable footnote (F1): The shares may be held by BEB Holdings, LLC. Mr. Burnam is the sole member of BEB Holdings, LLC and has sole voting and dispositive power over those shares, so shares held by the LLC may be deemed beneficially owned by him.
  • No indication in this filing of a 10b5-1 plan, tax withholding, option exercise, or late filing.

Context

  • Gifts are a transfer of shares and do not represent a market purchase signal; they generally do not by themselves indicate the insider’s view of the company’s near-term prospects. The filing shows a disposal by gift rather than a sale generating cash.